Industry in brief | Ipsen, Alliance Pharma, Sandoz

26 July 2019 - Deborah Wilkes

Archived

Ipsen has reported results for the first half of 2019, Alliance Pharma has released a trading update, and Novartis intends to keep its Sandoz generics business.

Click tags below for more information on topics:

Ipsen Alliance Pharma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: